Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SHAK | MCD |
|---|---|---|
| Price | $62.40 | $233.04 |
| Change today | ▲ 2.33% | ▲ 0.50% |
| Market cap | $2.52B | $164.91B |
| Return, 3 months | +13.6% | -16.8% |
| Return, year to date | -23.1% | -22.3% |
| Return, 1 year | -34.7% | -19.3% |
| P/E (TTM) | 65.7 | 18.9 |
| P/B | 4.6 | -161.2 |
| P/E percentile vs own 5y | 47th | 0th |
| Dividend yield | – | 3.15% |
| Revenue growth (YoY, latest qtr) | – | +3.8% |
| Net profit growth (YoY) | – | +4.8% |
| Gross margin | – | 57.4% |
| Operating margin | – | 45.7% |
| Net margin | – | 31.7% |
| Return on equity | – | – |
| Analyst target vs. price | +26.2% | +27.9% |
| Analyst buy share | 36% | 58% |
| RSI (14) | 53 | 27 |
| 30-day volatility | 44.8% | 20.8% |
| Max drawdown, 1 year | -50.0% | -31.0% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
